Tri-Service Buprenorphine Waiver Training Webinar

Official seals:Department of Defense, Military Health System, Department of Army, Department of Navy-United State Marine Corps, Department of the Navy, Department of the Air Force, Defense Health Agency

Webinar Dates:


 
Feb. 27, 2019
June 05, 2019
Sept. 4, 2019
Dec. 4, 2019
Webinar Times: 1:00 – 5:00 p.m. ET
Credit Designation: 5 AMA PRA Category 1 Credit(s)™
Course Topics:
 
- Review of Opioids                                  - Special Populations
- Introduction to Buprenorphine                - Overview Opioid Use Disorder Patient
- Confidentiality and Urine Drug Testing     - Evaluation, Clinical Uses
Course Director: Christopher Spevak, MD, MPH, JD
Director National Capital Region Opioid Safety Program

To Register: Send an email to the Psychological Health Center of Excellence (PHCoE) at
dha.ncr.j-9.mbx.phcoe-sud-support@mail.mil and include the following information:

  • Name

  • Rank and/or professional title (DoD or VA)

  • Phone number and email address

  • Preferred date of training webinar

  • City and state of your facility

Accreditation Statement:  This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the U.S. Navy Medical Command and WRNMMC. The U.S. Navy Medical Command is accredited by the ACCME to provide continuing medical education for physicians.

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (1U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. DATA Sponsor: The American Academy of Addiction Psychiatry